Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radical abdominal hysterectomy.

N R Abu-Rustum1, W J Hoskins

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

The Surgical Clinics of North America
|September 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increasing global accessibility to high-level treatments for cervical cancers.

Gynecologic oncology·2021
Same author

Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?

Gynecologic oncology·2021
Same author

A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer.

Archives of gynecology and obstetrics·2019
Same author

Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.

Gynecologic oncology·2018
Same author

Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

The impact of FDG-PET/CT in the management of patients with vulvar and vaginal cancer.

Gynecologic oncology·2016

Radical hysterectomy and pelvic lymphadenectomy are standard treatments for early cervical cancer, offering reliable cure rates. Ongoing research continues to refine neoadjuvant and adjuvant therapies for improved outcomes.

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology

Background:

  • Radical abdominal hysterectomy and pelvic lymphadenectomy are established as the gold standard for early cervical cancer treatment.
  • Advancements in gynecologic oncology training and surgical techniques have enhanced tumor resection and patient outcomes.

Purpose of the Study:

  • To review the current standard of care for early cervical cancer.
  • To discuss the evolving role of neoadjuvant and adjuvant therapies.

Main Methods:

  • Review of established surgical procedures.
  • Analysis of advancements in gynecologic oncology.
  • Consideration of emerging neoadjuvant and adjuvant treatment data.

Main Results:

  • Surgical resection with improved therapeutic index and cure rates achieved through established procedures.

Related Experiment Videos

  • Ongoing evaluation of neoadjuvant and adjuvant therapies based on emerging clinical trial data.
  • Conclusions:

    • Radical hysterectomy and pelvic lymphadenectomy remain the cornerstone of early cervical cancer management.
    • The precise role of neoadjuvant and adjuvant therapies is still being determined through ongoing research.